Blog

Feb’14 Alpha stock – A good Pharma company with great valuations Dear Readers, On 25th Feb’14 we released long/medium term investment recommendation for our Alpha and Alpha + members and would like to share with you details on the same especially if you like our research and our focus on high quality companies run by good management. Our last recommendation from Pharmaceutical Industry was IPCA Laboratories in Nov’12 at Rs 445 and the stock has appreciated by 100% since then to current…

Dear Readers, CARE Rating (NSE Code – CARERATING) was recommended to Alpha and Alpha plus members in Aug’13 when the stock was around 525. The detailed report on the same was also made public on 16th Nov’13 when the stock was around 700 (CMP – 850). In case you have invested in CARE, here’s an important update regarding the latest developments in the company. The Company recently informed exchanges that its principal shareholders, IDBI, along with four other shareholders, who hold…

Dear Readers, In this post we would like to discuss a micro cap stock Fluidomat (BSE Code – 522017). While small and micro cap stocks are fraught with risks, quick decision making and keeping a strong tab on the performance of such companies can also result in substantial gains. Also, until one is really confident of the business model and prospects of such companies, it’s important to not get emotionally attached and exit at first sight of deterioration in performance. Note: Please…

Dear Readers, SENSEX and NIFTY are near their life-time highs, however the retail investor’s interest in the market is completely lacking. The last 3-4 years have been excellent for those invested in stocks of high quality companies; however a large part of the investor community is nursing its wounds because of its love for gambling and speculative behavior. We believe, while it’s important to gain insights from those who have been unsuccessful (you can avoid same mistakes), it’s is even…